The Monopoly of Medicine: John D. Rockefeller, the Flexner Report, and the Marginalization of Holistic Health

Sep 22

4 min read

Introduction

At the turn of the 20th century, North American healthcare was characterized by a diverse, pluralistic marketplace of competing therapeutic systems. Over the subsequent three decades, this open landscape underwent a radical institutional transformation, consolidating into a singular, allopathic biomedical model. Central to this reorganization was the strategic deployment of corporate philanthropy, led by Andrew Carnegie and John D. Rockefeller, alongside the publication of Abraham Flexner’s landmark 1910 report on medical education. Through targeted financial endowments, standardized academic accreditation, and economic alignment with the synthetic pharmaceutical industry, Rockefeller’s philanthropic entities fundamentally reshaped American medical training. Consequently, holistic, botanical, and sectarian health practices were systematically marginalized from mainstream academic institutions.

The Pre-Flexner Landscape of Medical Pluralism

Prior to 1910, American medical care was delivered by a wide variety of practitioners, including eclectic physicians, homeopaths, naturopaths, osteopaths, herbalists, and midwives. Institutions such as the Eclectic Medical College of Cincinnati, established in 1845, provided rigorous instruction in plant pharmacology, nutrition, and botanical drug preparation derived from indigenous and folk traditions. This distributed healing tradition served urban centers as well as rural populations who lacked access to university hospitals. However, this pluralistic system was also criticized for its extreme variation in educational quality, as many proprietary, fee-funded medical schools operated with minimal laboratory infrastructure, lax entrance requirements, and insufficient clinical facilities.

The Flexner Report of 1910 and the Biomedical Standard

In 1908, the Carnegie Foundation for the Advancement of Teaching commissioned Abraham Flexner—a former educator trained at Johns Hopkins University who held no medical degree—to evaluate all 155 medical schools across the United States and Canada. Flexner evaluated each school against a single benchmark: the laboratory-intensive, research-focused, and hospital-affiliated curriculum of the Johns Hopkins University School of Medicine.

Published in 1910, the Flexner Report severely criticized proprietary and sectarian institutions, labeling non-allopathic approaches such as homeopathy and eclectic medicine as unscientific "dogma" and "quackery". Flexner recommended shutting down over half of all operating medical schools and enforcing a standardized four-year curriculum centered on laboratory science, bacteriology, and pharmaceutical chemistry.

Rockefeller Philanthropy and Strategic Capital Allocation

While Carnegie funded the initial survey, the implementation of Flexner’s recommendations was driven primarily by John D. Rockefeller’s philanthropic foundations, including the Rockefeller Foundation and the General Education Board. Operating in close coordination with the American Medical Association (AMA) Council on Medical Education, Rockefeller channeled tens of millions of dollars exclusively to allopathic university medical centers that adopted the Flexnerian standard, such as Johns Hopkins, Harvard, and Yale.

Medical education under the new laboratory model became prohibitively expensive for unendowed institutions. Starved of philanthropic capital and denied accreditation by state boards, non-conforming schools closed or merged in rapid succession, reducing the total number of North American medical schools from 155 in 1910 to 66 by 1935. This contraction disproportionately eliminated institutions that educated women, Black physicians, and rural practitioners.

Economic Alignment and the Rise of Patentable Pharmaceuticals

The institutional restructuring of medical education aligned with broader economic incentives in the burgeoning pharmaceutical sector. John D. Rockefeller’s industrial interests extended beyond oil refining into chemical and pharmaceutical manufacturing, which was adopting a European model of isolating and synthesizing patentable compounds derived from coal tar and chemical byproducts.

In contrast to unpatentable, whole-plant remedies and localized botanical preparations, synthetic compounds offered a highly lucrative business model based on intellectual property patents and controlled distribution supply chains. Medical school curricula were restructured around prescribers trained to administer patented synthetic drugs, transforming pharmacies from compounding operations into retail outlets for pre-manufactured pharmaceuticals. Non-monetized domestic remedies and botanical practices were thus economically excluded from the institutional billing and educational pipelines.

Legal Enforcement, AMA Regulation, and the Transformation of Psychiatry

The enforcement of this medical monopoly was carried out largely through expanded licensing authority granted to state medical boards and the AMA. Non-allopathic practitioners who continued to practice outside the accredited framework were reclassified from professional competitors to unscientific "quacks," and ultimately subjected to legal prosecution and criminal charges.

In specialized fields such as psychiatry, the Flexnerian shift dismantled holistic, community-based, and nutritional interventions, establishing a dominant biomedical and neurochemical framework centered on institutionalization and psychotropic drug therapies.

Historical Nuance and Distinguishing Fact from Myth

A critical academic analysis requires distinguishing the documented structural mechanisms of Rockefeller’s philanthropy from exaggerated historical myths. Fact-checking evaluations by organizations such as Science Feedback confirm that while Rockefeller’s financial endowments systematically prioritized allopathic, drug-oriented medical education, claims that Rockefeller personally lobbied Congress to outlaw natural healing or ordered the arrest and imprisonment of holistic doctors are unsubstantiated by historical records.

Additionally, historical records refute the myth that modern medicine completely abandoned natural origins, as numerous patented pharmaceuticals—including aspirin from willow bark, paclitaxel from Pacific yew, and artemisinin from annual mugwort—were developed directly from plant chemistry.

Long-Term Impact and Contemporary Resurgence

The lasting legacy of the Rockefeller-Flexner transformation was the institutional entrenchment of a disease-focused, symptom-oriented healthcare framework that largely excluded nutrition, preventive lifestyle practices, and botanical pharmacology from standard medical curricula. However, the late 20th and early 21st centuries have witnessed a significant cultural and scientific movement toward reintegrating these lost modalities. Through emerging frameworks such as integrative medicine, mind-body health, and functional medicine, contemporary healthcare is increasingly seeking to reconcile the scientific rigor of biomedicine with the holistic, patient-centered wisdom of historical healing traditions.